(Q40463893)

20 September 2017

title

Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes. (English)

1 reference

20 September 2017

main subject

Orthoebolavirus zairense

0 references

author name string

Krishnan Sundar

series ordinal

1

1 reference

20 September 2017

Agnieszka Boesen

series ordinal

2

1 reference

20 September 2017

Richard Coico

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

22 November 2006

1 reference

20 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

20 September 2017

volume

360

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

257-263

1 reference

Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

MHCBN: a comprehensive database of MHC binding and non-binding peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Experimental therapy of filovirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

MHC class I H-2Kd-restricted antigenic peptides: additional constraints for the binding motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Evaluation in nonhuman primates of vaccines against Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Persistent infection with ebola virus under conditions of partial immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Inactivated vaccine for Ebola virus efficacious in guineapig model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Mechanisms of MHC class I--restricted antigen processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Identification of murine T-cell epitopes in Ebola virus nucleoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Identification of a new HLA-A(*)0201-restricted T-cell epitope from the tyrosinase-related protein 2 (TRP2) melanoma antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Ebola virus-like particles protect from lethal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

Immunization for Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

In vivo priming of cytotoxic T lymphocyte responses in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.09.042

10.1016/J.VIROL.2006.09.042

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference